{
    "organizations": [],
    "uuid": "27b3b1a7cabf41276e702ed10c4b841696c1868f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-heron-therapeutics-reports-quarter/brief-heron-therapeutics-reports-quarterly-loss-per-share-of-0-81-idUSASC0A1FX",
    "ord_in_thread": 0,
    "title": "BRIEF-Heron Therapeutics Reports Quarterly Loss Per Share Of $0.81",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 10 (Reuters) - Heron Therapeutics Inc:\n* HERON THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018 AND RECENT CORPORATE PROGRESS\n* QUARTERLY LOSS PER SHARE $0.81 * REAFFIRMS FULL-YEAR 2018 CINV FRANCHISE NET PRODUCT SALES GUIDANCE OF $60 MILLION TO $70 MILLION\n* QTRLY NET PRODUCT SALES $11.6 MILLION VERSUS $3.6 MILLION Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-10T20:38:00.000+03:00",
    "crawled": "2018-05-11T13:10:37.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "heron",
        "therapeutic",
        "inc",
        "heron",
        "therapeutic",
        "announces",
        "financial",
        "result",
        "three",
        "month",
        "ended",
        "march",
        "recent",
        "corporate",
        "progress",
        "quarterly",
        "loss",
        "per",
        "share",
        "reaffirms",
        "cinv",
        "franchise",
        "net",
        "product",
        "sale",
        "guidance",
        "million",
        "million",
        "qtrly",
        "net",
        "product",
        "sale",
        "million",
        "versus",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}